Med@vice: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Med@vice
Largest movements
- Tangible fixed assets -€74,150
down €74,150 (-9.1%), from €814,011 to €739,861
of which Land and buildings: -€71,891
- Receivables within one year -€18,970
down €18,970 (-36.0%), from €52,666 to €33,696
of which Trade receivables: -€16,789
- Cash -€12,536
down €12,536 (-24.5%), from €51,187 to €38,651
mainly Debts after one year (-€125,311) and Advances received (-€25,497)
- Debts after one year -€125,311
down €125,311 (-27.0%), from €464,856 to €339,546
- Reserves +€43,846
up €43,846 (+12.8%), from €341,767 to €385,613
- Advances received -€25,497
no longer reported in 2025 (was €25,497)
- Write-downs +€15,406
no longer reported in 2025 (was -€15,406)
- Gross operating margin +€5,166
up €5,166 (+3.4%), from €150,752 to €155,918
- Depreciation -€2,664
down €2,664 (-5.4%), from €48,886 to €46,222
- Other operating charges +€1,955
up €1,955 (+38.8%), from €5,036 to €6,990
- Financial charges -€1,607
down €1,607 (-14.0%), from €11,506 to €9,899
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €921,601 | €814,424 | -€107,177 | -11.6% |
| Fixed assets | 21/28 | €814,011 | €739,861 | -€74,150 | -9.1% |
| Tangible fixed assets | 22/27 | €814,011 | €739,861 | -€74,150 | -9.1% |
| Land and buildings | 22 | €761,799 | €689,908 | -€71,891 | -9.4% |
| Plant, machinery and equipment | 23 | €3,629 | €2,723 | -€905 | -25.0% |
| Furniture and vehicles | 24 | €8,438 | €14,113 | +€5,675 | +67.3% |
| Other tangible fixed assets | 26 | €40,145 | €33,116 | -€7,029 | -17.5% |
| Current assets | 29/58 | €107,591 | €74,563 | -€33,028 | -30.7% |
| Amounts receivable within one year | 40/41 | €52,666 | €33,696 | -€18,970 | -36.0% |
| Trade receivables | 40 | €50,485 | €33,696 | -€16,789 | -33.3% |
| Other amounts receivable | 41 | €2,181 | - | -€2,181 | |
| Cash at bank and in hand | 54/58 | €51,187 | €38,651 | -€12,536 | -24.5% |
| Deferred charges and accrued income | 490/1 | €3,738 | €2,216 | -€1,522 | -40.7% |
| Total equity and liabilities | 10/49 | €921,601 | €814,424 | -€107,177 | -11.6% |
| Equity | 10/15 | €360,367 | €404,213 | +€43,846 | +12.2% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €341,767 | €385,613 | +€43,846 | +12.8% |
| Distributable reserves | 133 | €341,767 | €385,613 | +€43,846 | +12.8% |
| Amounts payable | 17/49 | €561,235 | €410,211 | -€151,023 | -26.9% |
| Amounts payable after more than one year | 17 | €464,856 | €339,546 | -€125,311 | -27.0% |
| Financial debts | 170/4 | €464,856 | €339,546 | -€125,311 | -27.0% |
| Amounts payable within one year | 42/48 | €96,378 | €70,666 | -€25,713 | -26.7% |
| Current portion of amounts payable after more than one year | 42 | €30,690 | €30,311 | -€379 | -1.2% |
| Trade debts | 44 | €25,102 | €24,383 | -€719 | -2.9% |
| Suppliers | 440/4 | €25,102 | €24,383 | -€719 | -2.9% |
| Advances received on contracts in progress | 46 | €25,497 | - | -€25,497 | |
| Taxes, remuneration and social security | 45 | €10,529 | €11,849 | +€1,320 | +12.5% |
| Taxes | 450/3 | €5,185 | €6,350 | +€1,165 | +22.5% |
| Remuneration and social security | 454/9 | €5,344 | €5,499 | +€155 | +2.9% |
| Other amounts payable | 47/48 | €4,560 | €4,123 | -€437 | -9.6% |
| Non-recurring operating income | 76A | €21,175 | €13,287 | -€7,888 | -37.3% |
| Remuneration, social security and pensions | 62 | €27,198 | €27,769 | +€570 | +2.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €48,886 | €46,222 | -€2,664 | -5.4% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | -€15,406 | - | +€15,406 | |
| Other operating charges | 640/8 | €5,036 | €6,990 | +€1,955 | +38.8% |
| Gross operating margin | 9900 | €150,752 | €155,918 | +€5,166 | +3.4% |
| Operating profit (loss) | 9901 | €85,038 | €74,938 | -€10,101 | -11.9% |
| Financial income | 75/76B | €2 | €1 | -€1 | -61.0% |
| Recurring financial income | 75 | €2 | €1 | -€1 | -61.0% |
| Financial charges | 65/66B | €11,506 | €9,899 | -€1,607 | -14.0% |
| Recurring financial charges | 65 | €11,506 | €9,899 | -€1,607 | -14.0% |
| Profit (loss) for the period before taxes | 9903 | €73,535 | €65,040 | -€8,495 | -11.6% |
| Income taxes | 67/77 | €21,687 | €21,194 | -€494 | -2.3% |
| Profit (loss) for the period | 9904 | €51,847 | €43,846 | -€8,001 | -15.4% |
| Profit (loss) for the period to be appropriated | 9905 | €51,847 | €43,846 | -€8,001 | -15.4% |
Source: filed annual accounts (NBB), fiscal years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 8 October 2026 via checked.be.